Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05885958 · ClinicalTrials.gov registry record · NA

Timing of Active Void Trials After Urogynecologic Procedures

A NA study of Postoperative Care and Urogynecology, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
231
Enrollment target
1
Study location

NCT05885958: Completed NA study of Postoperative Care and Urogynecology, sponsored by University of South Florida.

NCT05885958 is a NA study of Postoperative Care and Urogynecology that has completed, run by University of South Florida. The registered enrollment target is 231 participants, above the 90-participant average among 4 other Postoperative Care trials with a reported enrollment target (157% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05885958, a NA study of Postoperative Care and Urogynecology, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
231 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn about active void trial pass rates in patients undergoing urogynecologic surgery. The main question it aims to answer is the comparison in pass rate during active void trial between women who are given 30 minutes versus 60 minutes to void following urogynecologic surgery. Patient will be randomized to two arms prior to scheduled surgery. During the active void trial, women will be allotted up to 30 minutes or up to 60 minutes to void depending on respective randomization.

Primary Outcome

to compare the active void trial pass rate between arms

Interventions

  • OTHER Time

Study Locations (1)

Florida

  • USF Urogynecology Clinic - Tampa

Trial Details

FieldValue
Enrollment Target 231 participants
Start Date 2023-07-03
Est. Completion 2025-06-05
Phase NA
University of South Florida

252 total trials

What the finished NCT05885958 record still lists

NCT05885958 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, above the 90-participant average among 4 other Postoperative Care trials with a reported enrollment target (157% higher).

The record links to 3 conditions, with Postoperative Care appearing as the primary indexed condition, and to 1 intervention - of which Time is the first listed.

NCT05885958 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05885958 about?

NCT05885958 is a clinical study titled "Timing of Active Void Trials After Urogynecologic Procedures". The goal of this clinical trial is to learn about active void trial pass rates in patients undergoing urogynecologic surgery. The main question it aims to answer is the comparison in pass rate during active void trial between women who are given 30 minutes versus 60 minutes to void following urogyne...

What is the current status of trial NCT05885958?

This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2023-07-03. Estimated completion is 2025-06-05.

What conditions does trial NCT05885958 study?

This clinical trial studies the following conditions: Postoperative Care, Urogynecology, Urinary Catheters.

What interventions are being tested in trial NCT05885958?

The interventions under investigation include: Time (OTHER).

Who is sponsoring clinical trial NCT05885958?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05885958 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04077099 · 231 participants · Phase 1

    A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

  • NCT05019495 · 231 participants · NA

    Optimizing Tobacco Treatment Delivery for People Living With HIV

  • NCT06023589 · 231 participants · Phase 3

    A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

  • NCT06734351 · 231 participants · Phase 3

    A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05885958, the US trial registry maintained by the National Library of Medicine. NCT05885958 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.